Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Townsend Richard Nolan received 2,306 Lexeo Therapeutics, Inc. shares as an award (Form 4)

Traded Sep 14, 2026 · Filed Sep 28, 2026

On Sep 14, 2026, Townsend Richard Nolan (Director, Chief Executive Officer) received 2,306 Lexeo Therapeutics, Inc. shares as an award at US$2.64 for US$6,088, leaving 376,778 shares. Filed Sep 28, 2026 (Form 4).

Awarded
2,306 shares
Price
US$2.64
Value
US$6,088
Holding after
376,778 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 14, 2026Common StockAward2,306US$2.64376,778Direct

Source

View original at SEC

Related